1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If a molecule contains a chlorine atom (Cl), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If a molecule contains a phosphorus atom (P), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.

================================

1. Rule 1: If the molecule contains a functional group such as a carbonyl group (C=O) or a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If the molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If the molecule contains a polycyclic aromatic hydrocarbon (PAH) structure, it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.

================================

1. Rule 1: If a molecule contains a functional group such as an amidine group (-C=NH-), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If a molecule contains a functional group such as a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
These rules can be inferred by analyzing the structures of the molecules and identifying the presence of specific functional groups that are known to be associated with respiratory, thoracic, and mediastinal disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.

================================

Here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If the molecule contains a benzene ring (C6H5), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The molecule with label 1 in the given data contains a nitro group (-NO2). This suggests that the molecule is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: The molecule with label 1 in the given data contains a chlorine atom (-Cl). This suggests that the molecule is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: The molecule with label 1 in the given data contains a benzene ring (C6H5). This suggests that the molecule is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.

================================

1. Rule 1: If the molecule contains any functional groups such as aldehydes, ketones, amides, or carboxylic acids, it is more likely to cause adverse effects.
2. Rule 2: If the molecule has a high lipophilicity, it is more likely to cause adverse effects.
3. Rule 3: If the molecule has a high molecular weight, it is more likely to cause adverse effects.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If the molecule contains a benzene ring (C6H5), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
These rules are based on the fact that nitro groups and chlorine atoms are commonly found in molecules that cause adverse effects related to respiratory, thoracic, and mediastinal disorders. Benzene rings are also commonly found in molecules that cause adverse effects related to respiratory, thoracic, and mediastinal disorders. However, it is important to note that these rules are not foolproof and should be used with caution. It is always best to consult with a qualified chemist before making any decisions based on these rules.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If the molecule contains a benzene ring (C6H5), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

1. Rule 1: If the molecule contains a benzene ring, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If the molecule contains a nitro group, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If the molecule contains a chlorine atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
Explanation:
1. Rule 1 is based on the observation that benzene rings are commonly found in molecules that cause adverse effects related to respiratory, thoracic, and mediastinal disorders. Benzene rings are known to be toxic and can cause damage to the respiratory system. Therefore, if a molecule contains a benzene ring, it is likely to cause adverse effects related to these disorders.
2. Rule 2 is based on the observation that nitro groups are commonly found in molecules that cause adverse effects related to respiratory, thoracic, and mediastinal disorders. Nitro groups are known to be toxic and can cause damage to the respiratory system. Therefore, if a molecule contains a nitro group, it is likely to cause adverse effects related to these disorders.
3. Rule 3 is based on the observation that chlorine atoms are commonly found in molecules that cause adverse effects related to respiratory, thoracic, and mediastinal disorders. Chlorine atoms are known to be toxic and can cause damage to the respiratory system. Therefore, if a molecule contains a chlorine atom, it is likely to cause adverse effects related to these disorders.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If the molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
These rules can be inferred by analyzing the structures of the molecules and looking for the presence of specific functional groups or atoms that are known to be associated with adverse effects.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If a molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If a molecule contains a sulfur atom (-S), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carbonyl group (C=O), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If the molecule contains a chlorine atom, it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
These rules are based on the fact that the molecules in the dataset are related to respiratory, thoracic and mediastinal disorders, and that certain functional groups and atoms are more likely to cause adverse effects than others. However, it is important to note that these rules are not foolproof and should be used with caution.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If the molecule contains a sulfonamide group (-SO2NH2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If a molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If a molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
These rules can be inferred from the given data as follows:
1. The first molecule, with label 0, contains a carbonyl group (-C=O). This suggests that the molecule may have adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. The second molecule, with label 1, contains a chlorine atom (-Cl). This suggests that the molecule may have adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. The third molecule, with label 1, contains a nitro group (-NO2). This suggests that the molecule may have adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If a molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If a molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If the molecule contains a chlorine atom, it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If the molecule contains a halogen atom (-F, -Cl, -Br, -I), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

1. Rule 1: If the molecule contains a benzene ring, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If the molecule contains a carbonyl group, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If the molecule contains a halogen atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
These rules are based on the observation that benzene rings, carbonyl groups, and halogen atoms are common structural features of molecules that are associated with adverse effects related to respiratory, thoracic, and mediastinal disorders. However, it is important to note that these rules are not definitive and should be used as a starting point for further research and analysis.

================================

1. Rule 1: If the molecule contains a carbonyl group (C=O), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If a molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If a molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If a molecule contains a halogen atom (-F, -Cl, -Br, -I), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If a molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If a molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If a molecule contains a halogen atom (-F, -Cl, -Br, -I), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The first molecule, C1[C@H]([C@@H]2[C@H](O1)[C@H](CO2)O)O 1, contains a nitro group (-NO2). The second molecule, C1=C(C=C(C(=C1NC(=O)C(=O)O)Cl)NC(=O)C(=O)O)C#N.C(C(CO)(CO)N)O 1, also contains a nitro group (-NO2). The third molecule, [C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[Fe+2] 0, does not contain a nitro group. Therefore, the first two molecules are likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders, while the third molecule is not.
2. Rule 2: The first molecule, C1CC(CCC1OP(=O)([O-])OC[C@@H](CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-])(C2=CC=CC=C2)C3=CC=CC=C3.[Na+].[Na+].[Na+].[Gd+3] 1, contains a carbonyl group (-C=O). The second molecule, C1=C(C=C(C

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O) or a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If a molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If a molecule contains a polycyclic aromatic hydrocarbon (PAH) structure, it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.

================================

1. Rule 1: If the molecule contains a carbonyl group (C=O), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
4. Rule 4: If the molecule contains a double bond between carbon atoms, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
5. Rule 5: If the molecule contains a tertiary carbon atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
6. Rule 6: If the molecule contains a nitrogen atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

1. Rule 1: If the molecule contains a benzene ring, it is more likely to cause adverse effects.
2. Rule 2: If the molecule contains a carbonyl group, it is more likely to cause adverse effects.
3. Rule 3: If the molecule contains a nitro group, it is less likely to cause adverse effects.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carbonyl group (-C=O), it is more likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If the molecule contains a halogen atom (-Cl, -Br, -I), it is more likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If the molecule contains a nitro group (-NO2), it is more likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If a molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If a molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a halogen atom (-F, -Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects.
Explanation:
1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects. This is because nitro groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
2. Rule 2: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects. This is because carbonyl groups can react with other molecules such as amino groups in proteins, which can lead to toxicity and adverse effects.
3. Rule 3: The presence of a halogen atom (-F, -Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects. This is because halogen atoms can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.

================================

